Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Unattributed VC - II | Alive

Total Raised


Last Raised

$10.68M | 16 yrs ago

About Akela Pharma

Akela Pharma is a Healthcare/Drug Development company based in Austin, Texas. Akela Pharma's investors include Atlas Venture and Great Point Partners.

Akela Pharma Headquarter Location

11501 Domain Drive Suite 130

Austin, Texas, 78758,

United States


Latest Akela Pharma News

Akela Pharma, Inc. Announces Board of Director Transition - Press Releases

Jul 18, 2012

AUSTIN, TX, July 17, 2012 /PRNewswire/ - Akela Pharma, Inc. (TSX: AKL) today announced that Mr. Robert W. Rieder is stepping down as Chairman of the Board and as a member of the Board of Directors of Akela Pharma, Inc. to continue his focus as CEO and Director of ESSA Pharma, Inc. Akela also announced that Mr. Seth E. Lemler, of Lemler Capital Advisors, LLC, has joined Akela's Board of Directors and has been named Chairman of the Board. Mr. Rieder joined the Board of Akela in May o

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Akela Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Akela Pharma is included in 1 Expert Collection, including Biopharmaceuticals.



5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.